GALMED PHARMACEUTICALS LTD - SHS NEW (GLMD)

CUSIP: M47238122

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / SHS NEW
Total 13F shares
546,788
Share change
-144,650
Total reported value
$248,791
Price per share
$0.46
Number of holders
12
Value change
-$74,579
Number of buys
2
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP M47238122?
CUSIP M47238122 identifies GLMD - GALMED PHARMACEUTICALS LTD - SHS NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of GALMED PHARMACEUTICALS LTD - SHS NEW (GLMD) as of Q4 2023

As of 31 Dec 2023, GALMED PHARMACEUTICALS LTD - SHS NEW (GLMD) was held by 12 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 546,788 shares. The largest 10 holders included CVI Holdings, LLC, Walleye Capital LLC, MORGAN STANLEY, TWO SIGMA ADVISERS, LP, TWO SIGMA INVESTMENTS, LP, CITADEL ADVISORS LLC, WELLS FARGO & COMPANY/MN, Federation des caisses Desjardins du Quebec, OSAIC HOLDINGS, INC., and BOURGEON CAPITAL MANAGEMENT LLC. This page lists 12 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.